Skip to content

Effect of different doses of intravenous lidocaine on heart rate variability during anesthesia in bariatric surgery patients

Effect of different doses of intravenous lidocaine on heart rate variability during anesthesia in bariatric surgery patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300079086
Enrollment
Unknown
Registered
2023-12-25
Start date
2023-12-25
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome,bariatric surgery

Interventions

Group H:Lidocaine at 1.5 mg/kg was given as a loading dose 10 minutes before induction, and maintained at 1.5 mg/(kg?h) after induction
Group M:Lidocaine at 1.0 mg/kg was given as a loading dose 10 minutes before induction, and maintained at 1.0 mg/(kg?h) after induction
Group L:Lidocaine at 0.5 mg/kg was given as a loading dose 10 minutes before induction, and maintained at 0.5 mg/(kg?h) after induction
Group N:Equal volume of normal saline is given for loading and maintenance

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age:18-65 years old; 2.BMI=30kg/m2; 3. Patients undergoing elective laparoscopic gastric volume reduction surgery; 4. ASA grade II-III; 5. Sign the informed consent form;

Exclusion criteria

Exclusion criteria: 1. Patients who are allergic to amide drugs such as lidocaine; 2. Patients who need to be awake and intubated; 3. Patients with unsuccessful disposable endotracheal intubation; 4. Patients with bradycardia; 5. Patients with pheochromocytoma or hypertensive crisis; 6. Patients with severe cardiovascular diseases (such as myocardial infarction, heart failure, malignant arrhythmia, third-degree atrioventricular block, etc.); 7. Patients with hyperthyroidism and hyperthyroid crisis; 8. Patients who undergo bariatric surgery combined with other surgeries; 9. Patients who have been included in other interventional studies.

Design outcomes

Primary

MeasureTime frame
Heart rate variability;

Secondary

MeasureTime frame
Intraoperative hemodynamic changes;Perioperative opioid dosage;VAS score;Consumption of remedial analgesics within 24 hours;Postoperative nausea and vomiting grade;Consumption of salvage antiemetic medication within 24 hours;Incidence of intraoperative and postoperative adverse reactions to local anesthetics;Vasoactive drug usage rate;

Countries

China

Contacts

Public ContactWang Guanglei

Department of Anesthesiology, Affiliated Hospital of Xuzhou Medical University

wguanglei2000@163.com+86 138 5208 7156

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026